Sudarshan Pharma Industries Limited (BOM:543828)
31.90
+0.37 (1.17%)
At close: Nov 6, 2026
BOM:543828 Revenue
Sudarshan Pharma Industries had revenue of 2.17B INR in the quarter ending September 30, 2026, with 28.49% growth. This brings the company's total for the last twelve months to 7.80B, up 31.72% year-over-year. In the fiscal year ending March 31, 2026, Sudarshan Pharma Industries had annual revenue of 7.03B with 39.21% growth. That makes Sudarshan Pharma Industries the 24,107th largest company in the world by revenue and 1,495th in India.
Revenue (ttm)
7.80B
Revenue Growth
+31.72%
P/S Ratio
1.04
Revenue / Employee
121.92M
Employees
64
Market Cap
8.12B
Revenue by Geography
- India 6.81B 96.9%
- outside India 218.50M 3.1%
Fiscal year ended Mar 31, 2026 See the full BOM:543828 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.03B | 1.98B | 39.21% |
| Mar 31, 2025 | 5.05B | 414.94M | 8.95% |
| Mar 31, 2024 | 4.64B | 22.10M | 0.48% |
| Mar 31, 2023 | 4.61B | 1.04B | 29.19% |
| Mar 31, 2022 | 3.57B | 1.64B | 84.52% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| TTK Healthcare | 9.17B |
| Kopran | 7.94B |
| Anuh Pharma | 7.78B |
| Lincoln Pharmaceuticals | 7.22B |
| Wanbury | 6.53B |
| Amrutanjan Health Care | 5.27B |
| Fermenta Biotech | 5.11B |
| ZIM Laboratories | 4.13B |
Sudarshan Pharma Industries News
- 8 days ago - Sudarshan Pharma Industries Quarterly report: Q2 2027 - Filings
- 2 months ago - Sudarshan Pharma Industries Slides: Investor presentation - Filings
- 2 months ago - Sudarshan Pharma Industries Quarterly report: Q1 2027 - Filings
- 6 months ago - Sudarshan Pharma Industries Quarterly report: Q4 2026 - Filings
- 6 months ago - Sudarshan Pharma Industries Annual report: Q4 2026 - Filings
- 9 months ago - Sudarshan Pharma Industries Quarterly report: Q3 2026 - Filings